Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 6 most recent Form 4 transactions.
| Jun 9 | PRLD | Prelude Therapeutics Inc | AGRANT◆ | 38,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | — | Keenova Therapeutics plc | MEXER◆ | 4,882 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | — | Keenova Therapeutics plc | MEXER | 4,882 | — | — | +194.9% | Open the original filing on SEC.gov |
| May 20 | TCRX | TScan Therapeutics, Inc. | AGRANT◆ | 67,000 | — | — | — | Open the original filing on SEC.gov |